Skip to content

Weight management impact of "asken medical system" in patients with type 2 diabetes.

Weight management impact of "asken medical system" in patients with type 2 diabetes. - asknPEHR

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs052210213
Enrollment
62
Registered
2022-03-30
Start date
2022-05-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Sponsors

Ikeda Kaori
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Type 2 diabetes 2) Diabetic nephropathy stage 1 or 2 3) Aged 20 y.o. or older 4) BMI >= 25 5) HbA1c >= 6.5% 6) Mobile device user 7) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Using application assessing dietary intake 2) Pregnant or suspected to be pregnant 3) Breastfeeding 4) Less than 84 days after diagnosed with diabetes 5) Continuous administration of steroids 6) eGFR < 45ml/min/1.73cm2 7) Chronic pancreatitis or pancreatic cancer 8) Liver cirrhosis 9) Decompensated heart failure 10) Drug or alcohol dependence 11) Unstable mental disease 12) Malignant tumor 13) Comorbidity affecting primary outcome 14) Inappropriate for inclusion in the study

Design outcomes

Primary

MeasureTime frame
Body weight reduction (%) at 12 weeks

Secondary

MeasureTime frame
1) Body weight reduction (%) at 24 weeks 2) Change of clinical data (HbA1c, glycated albumin, LDL, HDL, urine Na, urine K) 3) Change of dietary intake 4) Change of dietary behavior 5) Chane of adherence score 6) Change of diabetes distress 7) Change of blood pressure 8) Optimization of medical nutrition therapy

Contacts

Public ContactKaori Ikeda

Kyoto University Hospital

krikeda@kuhp.kyoto-u.ac.jp+81-75-751-3560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026